CLINICAL_TRIALS
trial_result
· 2020-11-12
Clinical Trial Update: Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence [Phase 2]
Summary
Phase 2 study assessing enobosarm (GTx-024) in postmenopausal women with stress urinary incontinence has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GTx | Conditions: Stress Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2020-11-12